Selective T Cell Costimulation Modulator [EPC]

Selective T Cell Costimulation Modulator [EPC] was reported 139986 times

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 306 0.9107
1 RHEUMATOID FACTOR NEGATIVE 137 0.7829
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5524 0.7702
3 RHEUMATOID FACTOR POSITIVE 4329 0.7487
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 493 0.7380
5 RED BLOOD CELL SEDIMENTATION RATE 205 0.7348
6 PEMPHIGUS 8936 0.7140
7 SWOLLEN JOINT COUNT INCREASED 2275 0.7127
8 DEVICE SAFETY FEATURE ISSUE 697 0.7069
9 RHEUMATIC FEVER 3049 0.6833
10 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1506 0.6531
11 LUPUS VULGARIS 803 0.6373
12 DUODENAL ULCER PERFORATION 4619 0.6205
13 GRANULOMA SKIN 504 0.6139
14 HEPATIC ENZYME 91 0.6107
15 DEEP VEIN THROMBOSIS POSTOPERATIVE 1206 0.6021
16 HAND DEFORMITY 7844 0.5975
17 MUSCULOSKELETAL DEFORMITY 136 0.5812
18 GRIP STRENGTH 133 0.5808
19 SYNOVITIS 10468 0.5800
20 C-REACTIVE PROTEIN ABNORMAL 3718 0.5790
21 C-REACTIVE PROTEIN 521 0.5620
22 FACET JOINT SYNDROME 1725 0.5293
23 SWOLLEN JOINT COUNT 127 0.5080
24 BODY HEIGHT BELOW NORMAL 316 0.4914
25 MUSCLE INJURY 4044 0.4876
26 ATLANTOAXIAL INSTABILITY 54 0.4865
27 PRESBYACUSIS 147 0.4773
28 X-RAY ABNORMAL 854 0.4771
29 HELICOBACTER INFECTION 4818 0.4683
30 CONTRAINDICATED PRODUCT ADMINISTERED 14115 0.4657
31 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 964 0.4648
32 DISLOCATION OF VERTEBRA 1047 0.4586
33 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2978 0.4581
34 JOINT LAXITY 129 0.4272
35 FOLLICULITIS 4464 0.4253
36 BLOOD PARATHYROID HORMONE DECREASED 595 0.4012
37 ANTICIPATORY ANXIETY 109 0.4007
38 BONE EROSION 1375 0.3884
39 RETINITIS 663 0.3835
40 ELBOW DEFORMITY 132 0.3815
41 GLOSSODYNIA 8318 0.3712
42 SERONEGATIVE ARTHRITIS 423 0.3691
43 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 200 0.3565
44 RHEUMATOID NODULE 973 0.3529
45 DRUG TOLERANCE DECREASED 989 0.3518
46 PERICARDITIS 5888 0.3501
47 PERIPHERAL VENOUS DISEASE 1376 0.3366
48 HYPOCHOLESTEROLAEMIA 118 0.3343
49 MINERAL METABOLISM DISORDER 53 0.3333
50 INTESTINAL SEPSIS 78 0.2977
51 ANKLE ARTHROPLASTY 108 0.2975
52 SLE ARTHRITIS 81 0.2852
53 LOOSE BODY IN JOINT 73 0.2744
54 PANNICULITIS 651 0.2688
55 SYSTEMIC LUPUS ERYTHEMATOSUS 9545 0.2687
56 SPINAL INSTABILITY 66 0.2598
57 JOINT DESTRUCTION 399 0.2564
58 RHEUMATOID LUNG 241 0.2524
59 WOUND 7041 0.2516
60 WRIST DEFORMITY 146 0.2374
61 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2528 0.2282
62 RHEUMATOID ARTHRITIS 24856 0.2187
63 BREAST CANCER STAGE III 1395 0.2152
64 TEMPERATURE REGULATION DISORDER 478 0.2143
65 OVERLAP SYNDROME 150 0.2143
66 IRRITABLE BOWEL SYNDROME 4592 0.2139
67 ARTHROPATHY 11847 0.2129
68 TENOSYNOVITIS 583 0.2112
69 JOINT RANGE OF MOTION DECREASED 2643 0.1969
70 ONYCHOMADESIS 818 0.1947
71 JUVENILE IDIOPATHIC ARTHRITIS 474 0.1936
72 ARTHRODESIS 194 0.1906
73 LIP DRY 1689 0.1858
74 GRIP STRENGTH DECREASED 1627 0.1847
75 BURSITIS 2234 0.1839
76 DEVICE OPERATIONAL ISSUE 784 0.1821
77 PORPHYRIA ACUTE 255 0.1777
78 HYPERCHOLESTEROLAEMIA 1714 0.1773
79 NAIL OPERATION 72 0.1739
80 JOINT SWELLING 20948 0.1734
81 THERAPEUTIC PRODUCT EFFECT DECREASED 7760 0.1731
82 ONYCHOMYCOSIS 758 0.1726
83 PLEURAL THICKENING 118 0.1725
84 ENTHESOPATHY 263 0.1681
85 FIBROMYALGIA 3808 0.1565
86 WOUND INFECTION 1692 0.1544
87 FINGER DEFORMITY 747 0.1541
88 IMPAIRED HEALING 5009 0.1524
89 C-REACTIVE PROTEIN DECREASED 97 0.1485
90 PLEURAL FIBROSIS 151 0.1482
91 ANTIBODY TEST POSITIVE 234 0.1409
92 DRUG INTOLERANCE 13300 0.1375
93 LIVE BIRTH 1148 0.1371
94 MEAN PLATELET VOLUME DECREASED 113 0.1347
95 VASCULAR ACCESS COMPLICATION 109 0.1346
96 BLEPHAROSPASM 842 0.1336
97 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 105 0.1316
98 BLOOD MAGNESIUM INCREASED 116 0.1286
99 BONE DENSITY INCREASED 51 0.1278
100 AUTOIMMUNE DISORDER 1243 0.1274
101 FOOT DEFORMITY 1401 0.1263
102 BLOOD IRON ABNORMAL 123 0.1259
103 INFUSION SITE REACTION 374 0.1251
104 TREATMENT FAILURE 10006 0.1207
105 BONE CYST 113 0.1205
106 LIVER INJURY 2958 0.1204
107 LOWER RESPIRATORY TRACT INFECTION 5435 0.1194
108 TENOSYNOVITIS STENOSANS 66 0.1185
109 SCIATICA 1890 0.1184
110 HEPATIC ENZYME INCREASED 8050 0.1180
111 LIMB DEFORMITY 185 0.1164
112 POLYARTHRITIS 613 0.1162
113 BUNION OPERATION 65 0.1159
114 NAIL DISORDER 1014 0.1158
115 OBESITY 1840 0.1154
116 INFUSION RELATED REACTION 7542 0.1137
117 SKIN NEOPLASM EXCISION 89 0.1137
118 HIP ARTHROPLASTY 1721 0.1123
119 DEATH NEONATAL 155 0.1114
120 ALLERGY TO CHEMICALS 138 0.1108
121 JOINT ARTHROPLASTY 198 0.1105
122 NECK DEFORMITY 48 0.1081
123 PULMONARY FIBROSIS 2075 0.1081
124 PSORIATIC ARTHROPATHY 4374 0.1077
125 EXOSTOSIS 978 0.1070
126 SWELLING 9908 0.1058
127 COELIAC DISEASE 1032 0.1051
128 C-REACTIVE PROTEIN INCREASED 3821 0.1049
129 TYPE 2 DIABETES MELLITUS 3491 0.1036
130 SKIN NECROSIS 537 0.1034
131 BONE SWELLING 99 0.1023
132 ALANINE AMINOTRANSFERASE ABNORMAL 215 0.1018
133 KNEE ARTHROPLASTY 2143 0.1017
134 LOSS OF THERAPEUTIC RESPONSE 322 0.1009
135 SOFT TISSUE DISORDER 110 0.0992
136 APPARENT DEATH 350 0.0971
137 DRUG SPECIFIC ANTIBODY 130 0.0949
138 PRESCRIBED OVERDOSE 1831 0.0945
139 DISCOMFORT 5578 0.0913
140 MATERNAL EXPOSURE TIMING UNSPECIFIED 336 0.0894
141 WALKING AID USER 571 0.0865
142 OSTEOARTHRITIS 3651 0.0860
143 BLISTER 4815 0.0857
144 LUPUS-LIKE SYNDROME 771 0.0849
145 STOMATITIS 4997 0.0823
146 FINE MOTOR SKILL DYSFUNCTION 236 0.0815
147 FOOD ALLERGY 624 0.0808
148 BRONCHITIS CHRONIC 197 0.0806
149 DRUG TOLERANCE 403 0.0796
150 IMMUNODEFICIENCY 1181 0.0791
151 BLOOD CHOLESTEROL INCREASED 3676 0.0788
152 JOINT DISLOCATION 831 0.0785
153 LOWER LIMB FRACTURE 1493 0.0776
154 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3690 0.0767
155 PUSTULAR PSORIASIS 262 0.0762
156 BACK INJURY 828 0.0761
157 PEPTIC ULCER HAEMORRHAGE 53 0.0760
158 WRIST SURGERY 71 0.0759
159 INTERVERTEBRAL DISC SPACE NARROWING 61 0.0757
160 MUSCULOSKELETAL STIFFNESS 6597 0.0752
161 MEAN CELL VOLUME DECREASED 114 0.0739
162 OSTEOSCLEROSIS 116 0.0736
163 INFLAMMATION 3757 0.0727
164 LIVER FUNCTION TEST INCREASED 1559 0.0725
165 ORAL MUCOSAL EXFOLIATION 109 0.0720
166 ANKLE OPERATION 104 0.0704
167 PRURITUS ALLERGIC 82 0.0703
168 GAIT INABILITY 2346 0.0701
169 NIGHT SWEATS 2257 0.0700
170 MOBILITY DECREASED 5010 0.0697
171 OSTEOPOROTIC FRACTURE 133 0.0694
172 MEAN CELL HAEMOGLOBIN DECREASED 127 0.0693
173 PRESCRIBED UNDERDOSE 1384 0.0693
174 FRACTURE DELAYED UNION 57 0.0675
175 VASCULITIC RASH 52 0.0674
176 MATERNAL EXPOSURE DURING PREGNANCY 6001 0.0673
177 ILL-DEFINED DISORDER 4036 0.0664
178 PRODUCT LABEL CONFUSION 382 0.0655
179 SURGICAL FAILURE 75 0.0648
180 TUBERCULIN TEST POSITIVE 164 0.0647
181 SYNOVIAL CYST 293 0.0634
182 BLOOD FOLATE DECREASED 46 0.0633
183 MUSCULOSKELETAL PAIN 3292 0.0628
184 RHEUMATOID FACTOR INCREASED 70 0.0627
185 DEFORMITY 584 0.0624
186 CANCER SURGERY 59 0.0616
187 PRODUCT KNOWLEDGE DEFICIT 48 0.0614
188 ABDOMINAL DISCOMFORT 10301 0.0613
189 JOINT STIFFNESS 1604 0.0611
190 WHEELCHAIR USER 268 0.0602
191 INFECTION 8600 0.0594
192 SINUSITIS 6072 0.0592
193 BASAL CELL CARCINOMA 919 0.0588
194 JOINT EFFUSION 405 0.0587
195 SPONDYLITIS 211 0.0580
196 CONGENITAL ANOMALY 440 0.0568
197 ULCER HAEMORRHAGE 376 0.0555
198 DEMYELINATION 227 0.0553
199 RHEUMATIC DISORDER 107 0.0553
200 EYE INJURY 168 0.0552
201 FOOT OPERATION 272 0.0549
202 EAR PAIN 1068 0.0549
203 ALOPECIA 10772 0.0548
204 PERIPHERAL SWELLING 8413 0.0546
205 FOETAL DEATH 283 0.0545
206 SPINAL STENOSIS 224 0.0542
207 DISABILITY 1069 0.0540
208 PRODUCT CONTAMINATION PHYSICAL 137 0.0539
209 MUSCLE SPASTICITY 661 0.0537
210 BREAST CANCER STAGE II 444 0.0533
211 PULMONARY TOXICITY 376 0.0531
212 SLEEP DISORDER 3739 0.0529
213 GASTROINTESTINAL DISORDER 4743 0.0529
214 NEOPLASM SKIN 82 0.0528
215 CHONDROPATHY 143 0.0527
216 HYPERSENSITIVITY 9743 0.0524
217 ARTHRALGIA 21734 0.0522
218 INTESTINAL POLYP 85 0.0516
219 SPINAL FUSION SURGERY 208 0.0512
220 HYPERCALCAEMIA 624 0.0505
221 HEPATIC CIRRHOSIS 940 0.0500
222 SPINAL COLUMN INJURY 111 0.0498
223 THYROID NEOPLASM 136 0.0493
224 GENERAL PHYSICAL HEALTH DETERIORATION 5677 0.0490
225 ADVERSE EVENT 4504 0.0488
226 SKIN ULCER 1257 0.0486
227 COLITIS MICROSCOPIC 225 0.0475
228 CREPITATIONS 141 0.0473
229 NODULE 610 0.0467
230 INTENTIONAL PRODUCT USE ISSUE 4092 0.0467
231 LUNG DISORDER 2285 0.0466
232 THERAPY NON-RESPONDER 2090 0.0464
233 UTERINE DISORDER 108 0.0463
234 LIVER DISORDER 2043 0.0460
235 DEAFNESS NEUROSENSORY 151 0.0459
236 ADRENAL INSUFFICIENCY 550 0.0453
237 PRODUCT STORAGE ISSUE 170 0.0448
238 ARTHRITIS 3528 0.0448
239 INCORRECT PRODUCT STORAGE 584 0.0444
240 SCLERITIS 71 0.0443
241 DRUG ERUPTION 785 0.0443
242 BLOOD PRESSURE SYSTOLIC ABNORMAL 109 0.0441
243 SHOULDER ARTHROPLASTY 117 0.0434
244 INJURY 3033 0.0431
245 RASH VESICULAR 208 0.0430
246 PNEUMONIA VIRAL 137 0.0429
247 VIRAL UPPER RESPIRATORY TRACT INFECTION 203 0.0427
248 WHEEZING 2514 0.0424
249 UPPER RESPIRATORY TRACT INFECTION 1906 0.0412
250 OSTEOPOROSIS 1684 0.0409
251 ADVERSE REACTION 534 0.0402
252 PHYSICAL DISABILITY 177 0.0400
253 EXPOSURE DURING PREGNANCY 2453 0.0394
254 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2797 0.0393
255 EPICONDYLITIS 59 0.0391
256 DIVERTICULITIS 1081 0.0390
257 ATYPICAL MYCOBACTERIAL INFECTION 55 0.0389
258 ULCER 618 0.0388
259 HEPATITIS 988 0.0386
260 SENSITIVITY TO WEATHER CHANGE 203 0.0385
261 LIMB OPERATION 183 0.0381
262 EPIGASTRIC DISCOMFORT 149 0.0381
263 ROAD TRAFFIC ACCIDENT 1590 0.0380
264 CONTUSION 3637 0.0377
265 NASOPHARYNGITIS 6939 0.0376
266 INCORRECT STORAGE OF DRUG 65 0.0376
267 INVESTIGATION ABNORMAL 54 0.0376
268 OEDEMA 2034 0.0375
269 TASTE DISORDER 759 0.0374
270 BLOOD PRESSURE DIASTOLIC ABNORMAL 95 0.0373
271 RESPIRATORY DISORDER 1111 0.0371
272 OBLITERATIVE BRONCHIOLITIS 48 0.0366
273 PAIN 22227 0.0361
274 BODY TEMPERATURE INCREASED 736 0.0360
275 WHITE BLOOD CELL COUNT ABNORMAL 229 0.0358
276 PRODUCT TEMPERATURE EXCURSION ISSUE 183 0.0356
277 TONGUE DISORDER 257 0.0355
278 DEVICE MALFUNCTION 2488 0.0354
279 MONOCYTE COUNT INCREASED 128 0.0352
280 HEPATITIS B REACTIVATION 109 0.0343
281 PRODUCT USE ISSUE 6442 0.0342
282 SKIN PAPILLOMA 137 0.0341
283 JOINT INJURY 726 0.0340
284 SARCOIDOSIS 161 0.0339
285 ARTHRITIS INFECTIVE 157 0.0338
286 EAR INFECTION 889 0.0334
287 CONTRAST MEDIA ALLERGY 61 0.0333
288 CUTANEOUS VASCULITIS 121 0.0331
289 BACK DISORDER 535 0.0329
290 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 564 0.0329
291 IMMOBILE 143 0.0327
292 PREGNANCY 653 0.0326
293 NOROVIRUS INFECTION 47 0.0325
294 DRUG-INDUCED LIVER INJURY 991 0.0316
295 BREAST DISORDER 64 0.0313
296 NORMAL NEWBORN 170 0.0312
297 SPINAL DISORDER 293 0.0309
298 RASH 13429 0.0308
299 MUSCULOSKELETAL DISORDER 584 0.0307
300 POOR VENOUS ACCESS 316 0.0305
301 LOSS OF EMPLOYMENT 92 0.0304
302 CONDITION AGGRAVATED 9206 0.0302
303 FRACTURE 571 0.0301
304 DRUG INEFFECTIVE 39195 0.0297
305 BLOOD PRESSURE SYSTOLIC INCREASED 574 0.0294
306 MOUTH ULCERATION 619 0.0293
307 TOOTH INFECTION 384 0.0291
308 SERUM FERRITIN DECREASED 50 0.0289
309 BLOOD PRESSURE DIASTOLIC INCREASED 133 0.0288
310 HERPES ZOSTER 1653 0.0287
311 FOOD INTOLERANCE 105 0.0286
312 NECK MASS 81 0.0286
313 DELIRIUM 993 0.0286
314 MYCOBACTERIAL INFECTION 49 0.0284
315 NECK PAIN 1587 0.0284
316 DRUG USE DISORDER 238 0.0283
317 MYOSITIS 254 0.0283
318 DEVICE DEFECTIVE 490 0.0282
319 GENERAL SYMPTOM 211 0.0281
320 EPILEPSY 857 0.0280
321 THERAPY INTERRUPTED 2003 0.0280
322 HYPERTENSION 5895 0.0278
323 TERMINAL STATE 184 0.0275
324 LIMB DISCOMFORT 849 0.0274
325 DRY MOUTH 2223 0.0274
326 NEEDLE ISSUE 783 0.0269
327 CONFUSIONAL STATE 4333 0.0268
328 CATARACT OPERATION 159 0.0268
329 DERMATITIS ALLERGIC 337 0.0268
330 JOINT LOCK 76 0.0267
331 INTERSTITIAL LUNG DISEASE 1295 0.0267
332 URTICARIA 4470 0.0267
333 ACNE CYSTIC 80 0.0265
334 PRODUCT STORAGE ERROR 2322 0.0265
335 INFLAMMATORY MARKER INCREASED 131 0.0264
336 JAW FRACTURE 57 0.0264
337 THERAPEUTIC RESPONSE DECREASED 1589 0.0262
338 GLAUCOMA 500 0.0259
339 PULMONARY THROMBOSIS 283 0.0259
340 TENDON DISORDER 169 0.0259
341 OSTEOLYSIS 52 0.0254
342 LOCALISED INFECTION 613 0.0253
343 HEPATIC ENZYME ABNORMAL 126 0.0252
344 TOOTH DISORDER 557 0.0250
345 BREATH SOUNDS ABNORMAL 123 0.0249
346 WEIGHT INCREASED 5579 0.0249
347 ORAL SURGERY 58 0.0248
348 KERATITIS 74 0.0243
349 CARPAL TUNNEL SYNDROME 339 0.0242
350 HYPOAESTHESIA 3611 0.0241
351 BRONCHITIS 1778 0.0240
352 ORAL DISORDER 173 0.0236
353 LYMPHOMA 364 0.0235
354 DERMATITIS PSORIASIFORM 48 0.0235
355 GASTROINTESTINAL INFECTION 210 0.0234
356 BONE DENSITY ABNORMAL 87 0.0233
357 GASTROINTESTINAL TOXICITY 111 0.0231
358 HEPATIC FIBROSIS 79 0.0230
359 HEPATOTOXICITY 509 0.0228
360 LIMB MASS 50 0.0227
361 BONE DISORDER 413 0.0226
362 DYSPEPSIA 2210 0.0224
363 SKIN REACTION 315 0.0223
364 CYST 277 0.0223
365 IMPAIRED WORK ABILITY 477 0.0223
366 PRODUCT LEAKAGE 125 0.0223
367 RESPIRATORY TRACT CONGESTION 350 0.0220
368 DEVICE DELIVERY SYSTEM ISSUE 602 0.0220
369 APHTHOUS ULCER 170 0.0219
370 PAIN IN EXTREMITY 6450 0.0219
371 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 54 0.0218
372 BRONCHIECTASIS 146 0.0216
373 NERVE INJURY 240 0.0216
374 ADVERSE DRUG REACTION 1930 0.0215
375 NECK SURGERY 50 0.0215
376 LYMPHOPROLIFERATIVE DISORDER 63 0.0214
377 HEPATIC STEATOSIS 399 0.0214
378 FOOT FRACTURE 406 0.0214
379 ASTHMA 2398 0.0212
380 PRODUCT PREPARATION ISSUE 139 0.0212
381 MIGRAINE 2018 0.0211
382 LUNG ADENOCARCINOMA 63 0.0209
383 KIDNEY INFECTION 407 0.0207
384 TENDONITIS 321 0.0207
385 GRANULOMA 71 0.0205
386 RASH PRURITIC 1104 0.0203
387 PLEURITIC PAIN 56 0.0203
388 FEMUR FRACTURE 623 0.0201
389 POSTOPERATIVE WOUND INFECTION 135 0.0200
390 GASTROENTERITIS VIRAL 360 0.0199
391 MALIGNANT MELANOMA 266 0.0198
392 CATARACT 1181 0.0198
393 HYPERSENSITIVITY VASCULITIS 52 0.0198
394 INJECTION SITE REACTION 1361 0.0198
395 SKIN LACERATION 215 0.0198
396 OSTEOMYELITIS 357 0.0197
397 ADENOVIRUS INFECTION 57 0.0196
398 OSTEOPENIA 295 0.0194
399 ANTINUCLEAR ANTIBODY POSITIVE 63 0.0194
400 GASTRIC DISORDER 664 0.0193
401 TOOTH FRACTURE 213 0.0193
402 POST PROCEDURAL INFECTION 156 0.0192
403 ONYCHOCLASIS 131 0.0190
404 MULTIPLE ALLERGIES 149 0.0190
405 NEPHROLITHIASIS 871 0.0190
406 ACCIDENT 225 0.0188
407 VEIN DISORDER 94 0.0188
408 FATIGUE 14613 0.0187
409 ABDOMINAL PAIN UPPER 3861 0.0187
410 GAIT DISTURBANCE 3587 0.0187
411 PNEUMONIA 6024 0.0186
412 ANKYLOSING SPONDYLITIS 245 0.0186
413 SPINAL COLUMN STENOSIS 87 0.0184
414 BONE DENSITY DECREASED 575 0.0183
415 PNEUMOCYSTIS JIROVECII PNEUMONIA 184 0.0183
416 GASTRIC INFECTION 70 0.0183
417 ANAPHYLACTIC REACTION 1011 0.0183
418 TONGUE ULCERATION 61 0.0180
419 SHOULDER OPERATION 77 0.0180
420 INSURANCE ISSUE 273 0.0178
421 THYROID DISORDER 275 0.0178
422 DRUG SPECIFIC ANTIBODY PRESENT 116 0.0178
423 PULMONARY CONGESTION 235 0.0178
424 PHARYNGITIS 219 0.0176
425 EYE DISORDER 579 0.0176
426 AMNESIA 1141 0.0175
427 CUSHINGOID 56 0.0174
428 DEVICE FAILURE 265 0.0174
429 ANKLE FRACTURE 269 0.0174
430 WEIGHT FLUCTUATION 180 0.0172
431 TOOTH ABSCESS 175 0.0172
432 ARTHRITIS BACTERIAL 70 0.0170
433 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 47 0.0170
434 HIP SURGERY 92 0.0170
435 MUSCULAR WEAKNESS 1930 0.0170
436 ABSCESS LIMB 72 0.0169
437 RESPIRATORY TRACT INFECTION 440 0.0169
438 PYREXIA 5837 0.0169
439 INTERVERTEBRAL DISC DISORDER 72 0.0168
440 RED CELL DISTRIBUTION WIDTH INCREASED 70 0.0168
441 PLEURISY 100 0.0168
442 TENDERNESS 175 0.0168
443 LIVER FUNCTION TEST ABNORMAL 488 0.0168
444 LUMBAR SPINAL STENOSIS 49 0.0168
445 EYE INFECTION 189 0.0167
446 GOITRE 68 0.0166
447 FLUID RETENTION 842 0.0165
448 BEDRIDDEN 217 0.0165
449 MALAISE 7199 0.0164
450 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 277 0.0163
451 DEVICE LEAKAGE 707 0.0163
452 BLOOD PRESSURE DIASTOLIC DECREASED 120 0.0162
453 IMPAIRED GASTRIC EMPTYING 221 0.0162
454 ORAL INFECTION 63 0.0161
455 GASTROOESOPHAGEAL REFLUX DISEASE 1292 0.0160
456 CANDIDA INFECTION 271 0.0160
457 MEDICATION ERROR 888 0.0160
458 GASTROENTERITIS 233 0.0160
459 HERNIA 307 0.0159
460 PRURITUS 6101 0.0159
461 PRODUCT DISTRIBUTION ISSUE 147 0.0158
462 ORAL DISCOMFORT 220 0.0158
463 INFLUENZA 1751 0.0157
464 PSORIASIS 2050 0.0157
465 PELVIC FRACTURE 122 0.0157
466 KNEE OPERATION 153 0.0155
467 SKIN CANCER 334 0.0155
468 MASS 216 0.0154
469 HEADACHE 9643 0.0154
470 INSOMNIA 4083 0.0153
471 ASPARTATE AMINOTRANSFERASE INCREASED 814 0.0153
472 FEAR OF INJECTION 109 0.0153
473 ILLNESS 1557 0.0151
474 VASCULITIS 176 0.0151
475 ANAL ABSCESS 81 0.0150
476 HUMERUS FRACTURE 72 0.0149
477 SECRETION DISCHARGE 187 0.0149
478 MEMORY IMPAIRMENT 2048 0.0149
479 GINGIVITIS 80 0.0148
480 SURGERY 867 0.0148
481 ORAL HERPES 288 0.0147
482 IMMUNE SYSTEM DISORDER 194 0.0147
483 URINARY TRACT INFECTION 2503 0.0147
484 SEPTIC SHOCK 638 0.0146
485 PHOTOSENSITIVITY REACTION 242 0.0146
486 HERPES VIRUS INFECTION 84 0.0146
487 MULTIPLE FRACTURES 238 0.0145
488 SKIN INJURY 48 0.0145
489 STRESS FRACTURE 78 0.0144
490 DRUG EFFECT INCOMPLETE 523 0.0144
491 PULMONARY MASS 214 0.0144
492 ESCHERICHIA URINARY TRACT INFECTION 61 0.0143
493 IRON DEFICIENCY ANAEMIA 132 0.0143
494 SKIN MASS 95 0.0142
495 RASH ERYTHEMATOUS 679 0.0142
496 ALANINE AMINOTRANSFERASE INCREASED 871 0.0142
497 EYE OPERATION 65 0.0141
498 OFF LABEL USE 12277 0.0140
499 BREAST MASS 94 0.0140
500 SKIN INFECTION 157 0.0140
501 SUSPECTED OFF LABEL USE 63 0.0139
502 DIABETES MELLITUS 1062 0.0139
503 SPINAL PAIN 163 0.0139
504 UVEITIS 187 0.0138
505 UPPER LIMB FRACTURE 272 0.0136
506 PAIN IN JAW 384 0.0135
507 SPINAL COMPRESSION FRACTURE 112 0.0135
508 CYSTITIS 428 0.0134
509 DEVICE DEPLOYMENT ISSUE 171 0.0134
510 THROMBOCYTOSIS 49 0.0134
511 UROSEPSIS 123 0.0133
512 DRUG EFFECT DECREASED 718 0.0133
513 LEUKOPENIA 666 0.0133
514 LYMPHOEDEMA 92 0.0133
515 MUSCULOSKELETAL DISCOMFORT 228 0.0132
516 ROTATOR CUFF SYNDROME 170 0.0132
517 OEDEMA PERIPHERAL 1608 0.0132
518 INTERVERTEBRAL DISC PROTRUSION 288 0.0132
519 PARAESTHESIA 2070 0.0131
520 LABORATORY TEST ABNORMAL 387 0.0131
521 CHEST PAIN 2416 0.0130
522 LUNG INFECTION 201 0.0129
523 TIBIA FRACTURE 60 0.0128
524 FREQUENT BOWEL MOVEMENTS 345 0.0128
525 ERYSIPELAS 64 0.0127
526 BACK PAIN 2948 0.0127
527 ORAL CANDIDIASIS 167 0.0127
528 GALLBLADDER DISORDER 225 0.0126
529 VAGINAL INFECTION 59 0.0125
530 DECREASED IMMUNE RESPONSIVENESS 123 0.0125
531 VOMITING 5882 0.0125
532 TONSILLITIS 65 0.0124
533 SPINAL FRACTURE 248 0.0124
534 INFUSION SITE EXTRAVASATION 77 0.0124
535 PYELONEPHRITIS 106 0.0122
536 MENISCUS INJURY 75 0.0122
537 BODY TEMPERATURE DECREASED 120 0.0122
538 NEOPLASM MALIGNANT 813 0.0122
539 STENT PLACEMENT 98 0.0121
540 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 60 0.0120
541 EAR DISORDER 55 0.0120
542 SQUAMOUS CELL CARCINOMA 113 0.0120
543 HYPERTRANSAMINASAEMIA 83 0.0119
544 NERVE COMPRESSION 110 0.0119
545 SKIN LESION 326 0.0119
546 INJECTION SITE INFLAMMATION 59 0.0118
547 INTERVERTEBRAL DISC DEGENERATION 109 0.0118
548 SQUAMOUS CELL CARCINOMA OF SKIN 71 0.0117
549 DRY EYE 586 0.0117
550 HYPOGAMMAGLOBULINAEMIA 77 0.0117
551 SPINAL OPERATION 144 0.0117
552 PRODUCT USE IN UNAPPROVED INDICATION 2879 0.0116
553 MATERNAL EXPOSURE BEFORE PREGNANCY 79 0.0116
554 HAND FRACTURE 81 0.0114
555 EMPHYSEMA 115 0.0114
556 VISUAL IMPAIRMENT 1409 0.0114
557 FURUNCLE 90 0.0113
558 DEPRESSION 2576 0.0113
559 CYTOMEGALOVIRUS INFECTION REACTIVATION 50 0.0113
560 HOSPITALISATION 1736 0.0113
561 MUSCLE SPASMS 2068 0.0113
562 DECREASED APPETITE 2610 0.0112
563 MENINGITIS 75 0.0112
564 RIB FRACTURE 230 0.0112
565 WRIST FRACTURE 134 0.0112
566 VIRAL INFECTION 370 0.0111
567 GROIN PAIN 97 0.0110
568 QUALITY OF LIFE DECREASED 148 0.0110
569 MOVEMENT DISORDER 354 0.0110
570 DIARRHOEA 7070 0.0109
571 WHITE BLOOD CELL COUNT INCREASED 420 0.0109
572 SPINAL OSTEOARTHRITIS 96 0.0109
573 ACUTE GRAFT VERSUS HOST DISEASE 50 0.0109
574 DYSPNOEA 6146 0.0108
575 FALL 3610 0.0108
576 ENCEPHALITIS 75 0.0108
577 ARTHROPOD BITE 80 0.0108
578 UNDERDOSE 787 0.0108
579 CONJUNCTIVITIS 198 0.0107
580 TENDON RUPTURE 131 0.0106
581 NAUSEA 8373 0.0106
582 OROPHARYNGEAL PAIN 977 0.0105
583 COVID-19 1849 0.0105
584 HYPOCALCAEMIA 199 0.0105
585 TREATMENT NONCOMPLIANCE 574 0.0105
586 WEIGHT DECREASED 2922 0.0105
587 BLOOD IRON DECREASED 124 0.0104
588 TOOTH EXTRACTION 130 0.0104
589 HIATUS HERNIA 135 0.0104
590 RHINITIS 84 0.0104
591 PRODUCT PREPARATION ERROR 214 0.0104
592 INJURY ASSOCIATED WITH DEVICE 212 0.0104
593 VITAMIN D DEFICIENCY 101 0.0103
594 ASTHENIA 3890 0.0103
595 GASTRIC ULCER 196 0.0103
596 CELLULITIS 511 0.0101
597 DERMATITIS 211 0.0101
598 ENTEROCOLITIS 58 0.0100
599 HIP FRACTURE 323 0.0100
600 LIGAMENT SPRAIN 99 0.0100
601 INTENTIONAL DOSE OMISSION 285 0.0100
602 CORONAVIRUS INFECTION 66 0.0100
603 PLATELET COUNT INCREASED 130 0.0100
604 ORAL PAIN 223 0.0099
605 LIMB INJURY 269 0.0099
606 COLITIS ULCERATIVE 441 0.0099
607 SYRINGE ISSUE 172 0.0098
608 SUBCUTANEOUS ABSCESS 47 0.0098
609 EYE HAEMORRHAGE 130 0.0097
610 BLOOD PRESSURE FLUCTUATION 233 0.0097
611 RASH MACULO-PAPULAR 215 0.0097
612 PRODUCT SUPPLY ISSUE 67 0.0094
613 SINUS DISORDER 185 0.0093
614 COMPRESSION FRACTURE 50 0.0093
615 PRODUCTIVE COUGH 443 0.0093
616 HYPERKERATOSIS 51 0.0092
617 SKIN DISORDER 307 0.0092
618 ANGIOPATHY 51 0.0091
619 COUGH 2542 0.0091
620 LIQUID PRODUCT PHYSICAL ISSUE 66 0.0090
621 ERYTHEMA 1860 0.0090
622 CHOLECYSTECTOMY 103 0.0090
623 FEELING HOT 552 0.0090
624 DEEP VEIN THROMBOSIS 583 0.0090
625 ABDOMINAL PAIN 2086 0.0090
626 PANCREATITIS 471 0.0089
627 ECCHYMOSIS 61 0.0089
628 INGUINAL HERNIA 54 0.0089
629 RECTAL HAEMORRHAGE 379 0.0088
630 EPSTEIN-BARR VIRUS INFECTION 55 0.0088
631 PRODUCT ADMINISTRATION INTERRUPTED 69 0.0088
632 SPUTUM DISCOLOURED 83 0.0087
633 DIZZINESS 4364 0.0087
634 POLYP 57 0.0087
635 SEPSIS 962 0.0086
636 BODY HEIGHT DECREASED 92 0.0086
637 SKIN WARM 50 0.0086
638 BLOOD POTASSIUM INCREASED 139 0.0086
639 COVID-19 PNEUMONIA 99 0.0084
640 ANAPHYLACTIC SHOCK 215 0.0083
641 PNEUMONIA BACTERIAL 76 0.0083
642 GINGIVAL BLEEDING 113 0.0083
643 BACTERIAL INFECTION 154 0.0082
644 THERAPY CESSATION 422 0.0082
645 HYPERTENSIVE CRISIS 91 0.0082
646 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 424 0.0081
647 HAEMATOCRIT DECREASED 161 0.0081
648 BLOOD DISORDER 65 0.0081
649 NEOPLASM 93 0.0081
650 FUNGAL INFECTION 269 0.0081
651 PRODUCT DOSE OMISSION 522 0.0080
652 PRODUCT QUALITY ISSUE 1085 0.0080
653 DECUBITUS ULCER 65 0.0080
654 HYPERHIDROSIS 1027 0.0080
655 HEPATITIS B 48 0.0080
656 SWELLING OF EYELID 50 0.0080
657 LARGE INTESTINE POLYP 55 0.0079
658 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 267 0.0079
659 BLADDER DISORDER 78 0.0078
660 INABILITY TO AFFORD MEDICATION 78 0.0078
661 SEASONAL ALLERGY 111 0.0078
662 BURNING SENSATION 549 0.0078
663 TRANSAMINASES INCREASED 174 0.0078
664 HEART RATE DECREASED 274 0.0078
665 DIFFUSE LARGE B-CELL LYMPHOMA 60 0.0078
666 POST PROCEDURAL COMPLICATION 149 0.0078
667 GENERALISED OEDEMA 96 0.0077
668 THROMBOSIS 622 0.0077
669 ABDOMINAL DISTENSION 807 0.0077
670 ABSCESS 123 0.0077
671 MACULAR DEGENERATION 92 0.0077
672 INCORRECT DOSE ADMINISTERED BY DEVICE 201 0.0077
673 GENERAL PHYSICAL CONDITION ABNORMAL 52 0.0077
674 RED BLOOD CELL COUNT DECREASED 219 0.0077
675 THERMAL BURN 54 0.0076
676 DENTAL CARIES 84 0.0076
677 FLANK PAIN 71 0.0076
678 THYROID CANCER 91 0.0076
679 LUNG NEOPLASM MALIGNANT 310 0.0075
680 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 56 0.0075
681 RHINORRHOEA 479 0.0074
682 INFLUENZA LIKE ILLNESS 605 0.0073
683 BLOOD PRESSURE INCREASED 1122 0.0073
684 PULMONARY EMBOLISM 696 0.0073
685 RENAL CYST 58 0.0073
686 OVARIAN CANCER 67 0.0073
687 BREAST CANCER 677 0.0073
688 UTERINE LEIOMYOMA 53 0.0072
689 LOSS OF CONSCIOUSNESS 928 0.0072
690 BLOOD TEST ABNORMAL 101 0.0072
691 MUSCULOSKELETAL CHEST PAIN 111 0.0072
692 OPTIC NEURITIS 65 0.0071
693 COLON CANCER 106 0.0071
694 HYPOKALAEMIA 325 0.0070
695 LOCAL SWELLING 122 0.0070
696 INJECTION SITE BRUISING 553 0.0069
697 VITAMIN D DECREASED 59 0.0069
698 THROMBOCYTOPENIA 771 0.0069
699 DEAFNESS 180 0.0069
700 APHONIA 96 0.0069
701 LYMPHADENOPATHY 243 0.0069
702 RENAL IMPAIRMENT 573 0.0068
703 PLEURAL EFFUSION 414 0.0068
704 IMMUNOSUPPRESSION 60 0.0068
705 APPENDICITIS 63 0.0067
706 CARDIAC DISORDER 631 0.0067
707 AORTIC ANEURYSM 51 0.0067
708 RENAL DISORDER 311 0.0067
709 COLITIS 253 0.0067
710 ATRIAL FIBRILLATION 647 0.0066
711 EYE INFLAMMATION 63 0.0066
712 SUNBURN 49 0.0066
713 ESCHERICHIA INFECTION 54 0.0066
714 BLOOD CREATININE INCREASED 425 0.0065
715 NASAL CONGESTION 381 0.0065
716 CLOSTRIDIUM DIFFICILE INFECTION 141 0.0065
717 CARDIAC FAILURE 516 0.0064
718 NEURALGIA 156 0.0064
719 MOUTH HAEMORRHAGE 47 0.0064
720 GASTRITIS 168 0.0064
721 MUCOSAL INFLAMMATION 166 0.0063
722 CONCUSSION 49 0.0063
723 INJECTION SITE EXTRAVASATION 78 0.0063
724 INTENTIONAL PRODUCT MISUSE 548 0.0063
725 FACIAL PARALYSIS 53 0.0062
726 PNEUMONITIS 169 0.0062
727 LACERATION 58 0.0062
728 ATELECTASIS 59 0.0061
729 INCREASED TENDENCY TO BRUISE 56 0.0061
730 BLOOD PRESSURE ABNORMAL 121 0.0061
731 TOOTH LOSS 126 0.0061
732 WHITE BLOOD CELL COUNT DECREASED 658 0.0061
733 HAEMORRHOIDS 117 0.0060
734 INJECTION SITE HAEMORRHAGE 479 0.0060
735 MOTOR DYSFUNCTION 61 0.0060
736 OXYGEN SATURATION DECREASED 336 0.0060
737 OROPHARYNGEAL DISCOMFORT 54 0.0060
738 STAPHYLOCOCCAL INFECTION 194 0.0059
739 GINGIVAL PAIN 46 0.0058
740 MYOCARDIAL INFARCTION 1008 0.0058
741 ANXIETY 1636 0.0057
742 TOOTHACHE 104 0.0057
743 RESPIRATORY RATE INCREASED 51 0.0057
744 TACHYCARDIA 508 0.0057
745 FACIAL PAIN 51 0.0057
746 EMBOLISM 47 0.0057
747 HYSTERECTOMY 49 0.0057
748 DEMENTIA 158 0.0056
749 HAEMOGLOBIN DECREASED 580 0.0056
750 BRONCHOSPASM 80 0.0056
751 HUNGER 78 0.0056
752 PSEUDOMONAS INFECTION 48 0.0056
753 HAEMATOMA 144 0.0056
754 CARDIOVASCULAR DISORDER 141 0.0055
755 PHARYNGITIS STREPTOCOCCAL 60 0.0055
756 POLYNEUROPATHY 66 0.0055
757 FOETAL EXPOSURE DURING PREGNANCY 448 0.0055
758 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 255 0.0055
759 OVARIAN CYST 54 0.0054
760 NERVOUS SYSTEM DISORDER 168 0.0054
761 CHOLELITHIASIS 174 0.0053
762 PHARYNGEAL OEDEMA 81 0.0053
763 PRODUCT ADMINISTRATION ERROR 105 0.0052
764 SLEEP APNOEA SYNDROME 99 0.0052
765 THROAT TIGHTNESS 140 0.0052
766 INTESTINAL PERFORATION 58 0.0052
767 PHOTOPHOBIA 97 0.0052
768 DRUG EFFECT LESS THAN EXPECTED 76 0.0051
769 GOUT 92 0.0051
770 DYSPHONIA 298 0.0051
771 DEVICE ISSUE 454 0.0051
772 RENAL FAILURE 671 0.0050
773 CHOLECYSTITIS 60 0.0050
774 EATING DISORDER 107 0.0050
775 SCAR 86 0.0050
776 THERAPY PARTIAL RESPONDER 78 0.0050
777 ANGINA PECTORIS 143 0.0050
778 TRANSIENT ISCHAEMIC ATTACK 163 0.0048
779 PRODUCT DOSE OMISSION ISSUE 1407 0.0048
780 INJECTION SITE DISCOLOURATION 59 0.0047
781 BLOOD URINE PRESENT 89 0.0047
782 PERICARDIAL EFFUSION 108 0.0047
783 EXPOSURE VIA SKIN CONTACT 121 0.0047
784 PNEUMOTHORAX 74 0.0047
785 SINUS CONGESTION 63 0.0047
786 PRODUCT DOSE OMISSION IN ERROR 132 0.0047
787 PULMONARY OEDEMA 208 0.0046
788 INJECTION SITE SWELLING 354 0.0046
789 INJECTION SITE RASH 141 0.0046
790 NEUTROPHIL COUNT INCREASED 47 0.0046
791 DIABETES MELLITUS INADEQUATE CONTROL 81 0.0046
792 HYPOTHYROIDISM 146 0.0046
793 CHILLS 535 0.0046
794 SYNCOPE 452 0.0045
795 CYTOMEGALOVIRUS INFECTION 75 0.0045
796 HYPOACUSIS 194 0.0045
797 PROCEDURAL PAIN 125 0.0045
798 DRUG RESISTANCE 115 0.0045
799 POOR QUALITY PRODUCT ADMINISTERED 47 0.0045
800 MYOCARDITIS 51 0.0044
801 RENAL PAIN 47 0.0044
802 MYALGIA 753 0.0044
803 DEVICE USE ISSUE 77 0.0044
804 INTERNAL HAEMORRHAGE 50 0.0044
805 CEREBROVASCULAR ACCIDENT 740 0.0044
806 INJECTION SITE PRURITUS 289 0.0043
807 SCAB 49 0.0043
808 NEUTROPENIA 583 0.0043
809 GASTROINTESTINAL PAIN 47 0.0043
810 HEAD INJURY 133 0.0042
811 PARALYSIS 59 0.0041
812 SNEEZING 92 0.0041
813 THROAT IRRITATION 184 0.0041
814 SARS-COV-2 TEST POSITIVE 54 0.0041
815 FEELING ABNORMAL 978 0.0041
816 CARDIAC FAILURE CONGESTIVE 325 0.0040
817 PRURITUS GENERALISED 87 0.0040
818 PROTEINURIA 76 0.0040
819 HYPOKINESIA 58 0.0040
820 RASH MACULAR 138 0.0039
821 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 710 0.0039
822 SKIN DISCOLOURATION 181 0.0039
823 DYSSTASIA 115 0.0039
824 HEART RATE INCREASED 388 0.0039
825 CONSTIPATION 850 0.0039
826 DRUG DOSE OMISSION 641 0.0039
827 ACCIDENTAL EXPOSURE TO PRODUCT 398 0.0039
828 CARDIOMEGALY 47 0.0038
829 VERTIGO 232 0.0038
830 MYELODYSPLASTIC SYNDROME 55 0.0038
831 OVERDOSE 815 0.0038
832 INCORRECT PRODUCT ADMINISTRATION DURATION 81 0.0037
833 HOT FLUSH 281 0.0037
834 HEART RATE IRREGULAR 84 0.0037
835 ARRHYTHMIA 175 0.0037
836 RESTLESS LEGS SYNDROME 67 0.0037
837 HEAD DISCOMFORT 65 0.0037
838 SWELLING FACE 239 0.0037
839 CARDIOMYOPATHY 54 0.0037
840 DEATH 3143 0.0036
841 INFUSION SITE PAIN 47 0.0036
842 NEUROPATHY PERIPHERAL 346 0.0036
843 ANAEMIA 691 0.0036
844 ACUTE RESPIRATORY FAILURE 69 0.0036
845 DYSURIA 132 0.0036
846 BONE PAIN 207 0.0035
847 TINNITUS 162 0.0035
848 INTESTINAL OBSTRUCTION 132 0.0035
849 FEEDING DISORDER 71 0.0035
850 DEVICE DIFFICULT TO USE 231 0.0035
851 SKIN BURNING SENSATION 248 0.0035
852 HAEMATOCHEZIA 190 0.0034
853 CEREBRAL INFARCTION 84 0.0034
854 DRUG ADMINISTRATION ERROR 105 0.0034
855 PRODUCT DISPENSING ERROR 74 0.0034
856 DEVICE RELATED INFECTION 52 0.0034
857 INJECTION SITE ERYTHEMA 415 0.0033
858 POOR QUALITY SLEEP 72 0.0033
859 ABASIA 82 0.0033
860 ISCHAEMIC STROKE 59 0.0033
861 INJECTION SITE URTICARIA 81 0.0033
862 OCULAR HYPERAEMIA 156 0.0033
863 BRAIN FOG 51 0.0033
864 FEELING JITTERY 62 0.0033
865 ECZEMA 170 0.0032
866 LACRIMATION INCREASED 98 0.0032
867 FAECES DISCOLOURED 70 0.0032
868 NO ADVERSE EVENT 579 0.0032
869 RETCHING 67 0.0031
870 PLATELET COUNT DECREASED 331 0.0031
871 EYE PAIN 175 0.0031
872 PALPITATIONS 363 0.0031
873 BLOOD POTASSIUM DECREASED 93 0.0031
874 PANCYTOPENIA 172 0.0031
875 UNEVALUABLE EVENT 232 0.0031
876 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 167 0.0030
877 LIP SWELLING 101 0.0030
878 CHEST DISCOMFORT 308 0.0030
879 HYPOTENSION 598 0.0030
880 FEAR 80 0.0030
881 DYSPNOEA EXERTIONAL 110 0.0029
882 SWOLLEN TONGUE 91 0.0029
883 INJECTION SITE MASS 107 0.0029
884 ACUTE MYOCARDIAL INFARCTION 85 0.0029
885 CORONARY ARTERY DISEASE 87 0.0029
886 DISEASE PROGRESSION 334 0.0028
887 CHOKING 55 0.0028
888 HAEMORRHAGE 294 0.0028
889 SOMNOLENCE 566 0.0028
890 PELVIC PAIN 51 0.0028
891 ANGIOEDEMA 124 0.0028
892 BLOOD PRESSURE DECREASED 185 0.0028
893 BLOOD SODIUM DECREASED 52 0.0028
894 RESPIRATORY FAILURE 201 0.0028
895 COLD SWEAT 48 0.0027
896 DISEASE RECURRENCE 129 0.0027
897 BREAST CANCER FEMALE 71 0.0027
898 PULMONARY HYPERTENSION 55 0.0026
899 RASH GENERALISED 68 0.0026
900 ABORTION SPONTANEOUS 105 0.0026
901 EYE SWELLING 97 0.0026
902 TREMOR 430 0.0026
903 PROSTATE CANCER 208 0.0026
904 BLINDNESS 105 0.0026
905 GAMMA-GLUTAMYLTRANSFERASE INCREASED 57 0.0026
906 BONE MARROW FAILURE 51 0.0025
907 GASTRIC CANCER 63 0.0025
908 MENTAL STATUS CHANGES 68 0.0024
909 PNEUMONIA ASPIRATION 61 0.0024
910 EYE PRURITUS 82 0.0024
911 PRODUCT PRESCRIBING ISSUE 53 0.0024
912 INJECTION SITE PAIN 742 0.0024
913 VISION BLURRED 327 0.0024
914 MOOD SWINGS 75 0.0024
915 SPEECH DISORDER 123 0.0023
916 FEELING COLD 65 0.0023
917 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
918 LETHARGY 134 0.0023
919 DEHYDRATION 310 0.0023
920 EPISTAXIS 171 0.0023
921 FLUSHING 232 0.0023
922 ACNE 171 0.0023
923 URINARY INCONTINENCE 65 0.0022
924 HAEMOPTYSIS 61 0.0022
925 DYSPHAGIA 207 0.0022
926 RESPIRATORY DISTRESS 60 0.0022
927 THERAPEUTIC RESPONSE SHORTENED 71 0.0021
928 POLLAKIURIA 89 0.0021
929 PRODUCT PRESCRIBING ERROR 50 0.0021
930 RASH PAPULAR 47 0.0021
931 DEVICE BREAKAGE 85 0.0021
932 MENTAL DISORDER 90 0.0021
933 FLATULENCE 117 0.0021
934 BLOOD ALKALINE PHOSPHATASE INCREASED 51 0.0021
935 OSTEONECROSIS 67 0.0020
936 TOXICITY TO VARIOUS AGENTS 341 0.0020
937 EYE IRRITATION 115 0.0020
938 DRY SKIN 266 0.0020
939 OSTEONECROSIS OF JAW 49 0.0020
940 DRUG DEPENDENCE 317 0.0020
941 HYPONATRAEMIA 109 0.0019
942 PRESYNCOPE 47 0.0019
943 ANGER 65 0.0019
944 BALANCE DISORDER 165 0.0019
945 DIPLOPIA 48 0.0018
946 CHRONIC KIDNEY DISEASE 137 0.0018
947 PANCREATIC CARCINOMA 52 0.0018
948 MULTIPLE SCLEROSIS 86 0.0018
949 HYPOXIA 63 0.0018
950 CEREBRAL HAEMORRHAGE 64 0.0018
951 EMOTIONAL DISORDER 55 0.0018
952 NERVOUSNESS 93 0.0018
953 DRUG INTERACTION 279 0.0018
954 DEPRESSED MOOD 92 0.0017
955 PANIC ATTACK 62 0.0017
956 DEVICE USE ERROR 59 0.0017
957 HYPOGLYCAEMIA 82 0.0017
958 SKIN EXFOLIATION 142 0.0017
959 RESPIRATORY ARREST 46 0.0017
960 APHASIA 50 0.0017
961 BLOOD GLUCOSE INCREASED 311 0.0016
962 URINARY RETENTION 55 0.0016
963 HYPERSOMNIA 46 0.0016
964 ACUTE KIDNEY INJURY 244 0.0016
965 SEIZURE 184 0.0016
966 HEPATIC FUNCTION ABNORMAL 58 0.0016
967 MYELOSUPPRESSION 55 0.0015
968 INCORRECT DOSE ADMINISTERED 348 0.0015
969 VISUAL ACUITY REDUCED 50 0.0015
970 NEUTROPHIL COUNT DECREASED 61 0.0015
971 GASTROINTESTINAL HAEMORRHAGE 119 0.0014
972 SUICIDAL IDEATION 130 0.0014
973 DRUG DOSE OMISSION BY DEVICE 111 0.0014
974 BLOOD GLUCOSE DECREASED 68 0.0014
975 BLADDER CANCER 82 0.0014
976 MALIGNANT NEOPLASM PROGRESSION 140 0.0014
977 DYSGEUSIA 100 0.0013
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 271 0.0013
979 ACCIDENTAL OVERDOSE 48 0.0013
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 93 0.0013
981 CARDIAC ARREST 107 0.0013
982 COMA 60 0.0013
983 PLASMA CELL MYELOMA 47 0.0012
984 COGNITIVE DISORDER 52 0.0011
985 SKIN IRRITATION 47 0.0010
986 RENAL CANCER 48 0.0010
987 BRADYCARDIA 46 0.0009
988 IRRITABILITY 52 0.0009
989 HALLUCINATION 61 0.0008
990 AGITATION 53 0.0007